| 2021 | 2020 | ||||||
|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | ||||
| fund | funds | funds | funds | ||||
| Notes | F | ||||||
| INCOME AND ENDOWMENTS | FROM | ||||||
| Donations and legacies |
3 | 1,726,274 | 1,726,274 | 1,053,057 | |||
| Other trading activities |
4 | 324,408 | 324,408 | 1,027,062 | |||
| Investment income |
5 | 104,967 | 104,967 | 114,321 | |||
| Other income | 6 | 59,362 | 59,362 | 20,701 | |||
| Total | 2,215,011 | 2,215,011 | 2,215,141 | ||||
| EXPENDITURE ON | |||||||
| Raising funds | 583,814 | 583,814 | 862,505 | ||||
| Charitable activities |
|||||||
| Research projects | 883,695 | 8,397 | 892092 | 2 544 440 | |||
| Total | 1,467,509 | 8,397 | 1,475,906 | 3,406,945 | |||
| Net gains/(losses) on |
investments | 756,570 | 756.570 | ~155,705) | |||
| NET INCOME/(EXPENDITURE) | 1,504,072 | (8,397) | 1,495,675 | (1,347,509) | |||
| RECONCILIATION OF FUNDS |
|||||||
| Total funds brought | forward | 3,455,034 | 365,408 | 3,820,442 | 5,167,951 | ||
| TOTAL FUNDS CARRIED FORWARD | 4,959,106 | 357,011 | 5,316,117 | 3,820,442 |
| 2021 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Urfrestricted | Restrfrsted | Total | Tefal | |||||
| fUnd | iUnci 5 | IUIICo | fUI '.ras |
|||||
| C | k | 6 | ||||||
| FlXED ASSETS li rtai19fbtLa assetS Tal"I&I".bfe issets ff1VLasf irrerfte |
trrf 17 I or |
«,889 2='i,!82 *.301..:65 |
4,889 25,782 !,80i,865 |
9 !8eJ 29 !35-1 3.I88, 05 |
||||
| 4,832,536 | 4,8 r2,53!& | ",' 'L'I.-, U18 | ||||||
| CURRENT ASSETS Qebtors Cash ai barite arid i'.1 "Brief |
:9 | 7 '.9,258 2,807,760 |
365a408 | 749 r58 3,1 s3.168 |
508, 774 3 f24,957 |
|||
| 3557,018 | 365.-'08 | 3,922.426: .533731 | ||||||
| CREDITORS Ai'IIC'irrtftS ialllflti 6'I . VSil)iln «iii |
)refdr | 20 | i;620428t | i8 3$71 | i'628,825; | f396,34"i; | ||
| NET CUPPENT ASSETS | ;?,936,590 | 357,0t | 1 | 3, .9i,601 | 3il37,390 | |||
| TOT~P ASSETS |
LESSCURRENT UABiLITfES | i',769,126 | 35,0 | 1 | 8.t26it37 | 7,184,038 | ||
| PRGVfSIONS FOR LfABILfTfES | 22 | !2,8 f0,020) | (2,810,020 i | (3,34':.598( | ||||
| l,959,":0I6 | 37ti"1 | ~ !6i 7 | 3 II2s0,442 | |||||
| Unre Iri-ted!!Inde |
4,95Cs,106 | ~,»5-,0s4 | ||||||
| Lostnctedi ',Uirds |
||||||||
| TOTALFUNDS | 5.316,117 | "-',820,442 |
| 2021 | 2020 | |||
|---|---|---|---|---|
| Notes | E | F | ||
| Cash flows from operating | activities | |||
| Cash generated from operations |
104,805 | 238,121 | ||
| Interest paid | 5 | |||
| Net cash provided by operating activities |
104,805 | 238,126 | ||
| Cash flows from investing | activities | |||
| Purchase of intangible fixed assets Purchase oftangible fixed assets |
(4,670) | (11,935) (14,340) |
||
| Purchase offixed asset investments Sale of intangible fixed assets Sale oftangible fixed assets |
(1,064,361) | (1,263,532) (30,530) 38,530 |
||
| Sale offixed asset investments | 1,007,471 | 1,169,718 | ||
| Interest received | 18,064 | 19,363 | ||
| Dividends received |
86,902 | 94,958 | ||
| Net cash (used in)/provided | by investing | activities | 43,406 | 2,232 |
| Change in cash and cash |
equivalents | in | ||
| the reporting period |
148,211 | 240,358 | ||
| Cash and cash equivalents | at the | |||
| beginning ofthe reporting |
period | 3,024,957 | 2,784,599 | |
| Cash and cash equivalents | at the end | of | ||
| the reporting period |
3,173,168 | 3,024,957 |
| ACTIVITIES | ||||||
|---|---|---|---|---|---|---|
| 2021 | 2020 | |||||
| F | f | |||||
| Net income/(expenditure) | for the reporting | period (as per the | ||||
| Statement of Financial Activities) Adjustments for: |
1,495,675 | (1,347,509) | ||||
| Depreciation charges |
12,242 | 15,044 | ||||
| (Gain)/losses on investments |
(786,038) | 202,311 | ||||
| Loss on disposal of | fixed assets | 30,546 | ||||
| Interest received | (18,064) | (19,363) | ||||
| Interest paid Dividends received |
(86,902) | (5) (94,958) |
||||
| Discounting of provisions |
29,468 | (18,720) | ||||
| Dilapidations provision |
150,996 | |||||
| Decrease in stocks |
1,120 | |||||
| (Increase)/decrease | in debtors | (240,484) | 487,321 | |||
| (Decrease)/increase | in creditors | ~3O1,092 | 831,338 | |||
| Net cash provided | by operations | 104,805 | 238,121 | |||
| ANALYSIS OF CHANGES | IN NET FUNDS | |||||
| At 1/4/20 F |
Cash flow f |
At 31/3/21 F |
||||
| Net cash | ||||||
| Cash at bank and in | hand | 3,024,957 | 148,211 | 3,173,168 | ||
| 3,024,957 | 148,211 | 3,173,168 | ||||
| Total | 3,024,957 | 148,211 | 3,173,168 |
| OTHER INCOME | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | |||||||
| F | ||||||||
| Discounting of provisions |
(29,468) | 18,720 | ||||||
| Insurance claim |
85,830 | |||||||
| Miscellaneous income |
3,000 | 1,981 | ||||||
| 59,362 | 20,701 | |||||||
| RAISING FUNDS | ||||||||
| Raising donations | and | legacies | ||||||
| 2021 | 2020f | |||||||
| Fundraising staff costs |
211,940 | 192,040 | ||||||
| Gift aid and legacy | expenses | 3,513 | 6,710 | |||||
| Events and general | fundraising | expenditure | 11,002 | 68,819 | ||||
| Advertising and publicity |
928 | 9,836 | ||||||
| Other fundraising expenses |
6,180 | 24,638 | ||||||
| Depreciation | 412 | 476 | ||||||
| 233,975 | 302,519 | |||||||
| Other trading activities | ||||||||
| 2021 | 2020 | |||||||
| Retail staff costs | 151,434 | 169,299 | ||||||
| Retail purchases | 920 | 7,038 | ||||||
| Retail and warehouse | premises | costs | 131,348 | 143,109 | ||||
| Other retail costs | 24,301 | 44,849 | ||||||
| Merchandise purchases |
including | Christmas | cards | 3,985 | 4,814 | |||
| Dilapidations | 150,996 | |||||||
| Depreciation | 7,255 | 9,718 | ||||||
| Loss on sale ofassets | 16 | |||||||
| 319,243 | 529,839 |
| RAISING FUNDS - continued | RAISING FUNDS - continued | RAISING FUNDS - continued | RAISING FUNDS - continued | RAISING FUNDS - continued | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Investment | management | costs | ||||||||
| 2021 | 2020 | |||||||||
| F | ||||||||||
| Investment | management | costs | 30,596 | 30,147 | ||||||
| Aggregate | amounts | 583,814 | 862,505 | |||||||
| CHARITABLE ACTIVITIES COSTS | ||||||||||
| Grant | ||||||||||
| funding | of | |||||||||
| Direct | activities | Support | ||||||||
| Costs (see | (see note | costs (see | ||||||||
| note 9) | 10) | note 11) | Totals | |||||||
| F | F | F | ||||||||
| Research | projects | 126,302 | 456,287 | 309,503 | 892,092 | |||||
| DIRECT COSTS OF CHARITABLE ACTIVITIES | ||||||||||
| 2021 | 2020 | |||||||||
| F | F | |||||||||
| Staff costs | 96,568 | 86,886 | ||||||||
| Direct cancer research | expenditure | 20,740 | (3,811) | |||||||
| Science communication | costs | 8,719 | 320 | |||||||
| Depreciation | 275 | 317 | ||||||||
| 126,302 | 83,712 | |||||||||
| GRANTS | PAYABLE | |||||||||
| 2021 | 2020 | |||||||||
| F | F | |||||||||
| Research | projects | 456,287 | 2,117,505 | |||||||
| The total grants paid to |
institutions | during the year | was as follows: | |||||||
| 2021 | 2020 | |||||||||
| F | ||||||||||
| Velindre NHS Trust |
147,731 | 79,341 | ||||||||
| Cardiff University | 266,132 | 1,571,045 | ||||||||
| Bangor University Other adjustments |
on project closures | 47,000 ~4,576) |
481,322 ~14,203) |
|||||||
| 456,287 | 2,117,505 |
| STAFF COS | TS | ||||||
|---|---|---|---|---|---|---|---|
| 2021 | 2020 | ||||||
| f. | f | ||||||
| Wages and salaries | 575,617 | 553,227 | |||||
| Redundancy | costs | 23,855 | |||||
| Social security costs | 52,819 | 46,787 | |||||
| Pension | 50,760 | 46,141 | |||||
| 703,051 | 646,155 | ||||||
| The average | monthly | number ofemployees | during the year was as follows: | ||||
| 2021 | 2020 | ||||||
| Fundraising | 6 | 6 | |||||
| Retail | 7 | 7 | |||||
| Administration/ | Governance | 6 | 7 | ||||
| 19 | 20 | ||||||
| The number | ofemployees | whose emoluments | amounted | toa rate ofover F60,000 | during the year were as follow | ||
| 2021 | 2020 | ||||||
| No. | No. | ||||||
| F60,001 - F70,000 | 1 | ||||||
| Pension contributions | 9,100 |
| Unrestricted | Restricted | Total | |||
|---|---|---|---|---|---|
| fund | funds | funds | |||
| F | |||||
| INCOME AND ENDOWMENTS | FROM | ||||
| Donations and legacies |
1,053,057 | 1,053,057 | |||
| Other trading activities |
981,074 | 45,988 | 1,027,062 | ||
| Investment income |
114,321 | 114,321 | |||
| Other income | 20,701 | 20,701 | |||
| Total | 2,169,153 | 45,988 | 2,215,141 | ||
| EXPENDITURE ON | |||||
| Raising funds | 862,505 | 862,505 | |||
| Charitable activities |
|||||
| Research projects | 2,544,440 | 2,544,440 | |||
| Total | 3,406,945 | 3,406,945 | |||
| Net gains/(losses) on |
investments | ~155,705) | ~155,705) | ||
| NET INCOME/(EXPENDITURE) | (1,393,497) | 45,988 | (1,347,509) | ||
| RECONCILIATION OF FUNDS |
|||||
| Total funds brought | forward | 4,848,531 | 319,420 | 5,167,951 | |
| TOTAL FUNDS CARRIED FORWARD | 3,455,034 | 365,408 | 3,820,442 |
| 2021 | 2020 | |||||||
|---|---|---|---|---|---|---|---|---|
| Financial | assets | F | F | |||||
| Financial | assets that are debt instruments | measured | at amortised | cost | 3,898,333 | 3,502,762 | ||
| Financial | assets measured | at fair value | 4,689,108 | 3,988,405 | ||||
| 2021 | 2020 | |||||||
| Financial | liabilities | |||||||
| Financial | liabilities | measured | at amortised | cost | 475,288 | 396,341 | ||
| Financial | liabilities | measured | at fair value | 2,810,020 | 3,343,596 |
| INTANGIBLE FIXEDASSETS | |
|---|---|
| Computer | |
| software | |
| P | |
| COST | |
| At 1 April 2020 and 31 March 2021 | 14,922 |
| AMORTISATION | |
| At 1 April 2020 | 5,733 |
| Charge for year | 4,300 |
| At 31 March 2021 | 10,033 |
| NET BOOK VALUE | |
| At 31 March 2021 | 4,889 |
| At 31 March 2020 | 9,189 |
| TANGIBLE FIXEDASSETS | ||||
|---|---|---|---|---|
| Leasehold | ||||
| property | Fixtures | Motor | ||
| improvements | 8 Equipment | vehicles | Totals | |
| COST | ||||
| At 1 April 2020 | 103,101 | 37,897 | 20,216 | 161,214 |
| Additions | 4,670 | 4,670 | ||
| At 31 March 2021 | 107,771 | 37,897 | 20,216 | 165,884 |
| DEPRECIATION | ||||
| At 1 April 2020 | 96,971 | 18,342 | 16,847 | 132,160 |
| Charge for year | 3,027 | 3,611 | 1,304 | 7,942 |
| At 31 March 2021 | 99,998 | 21,953 | 18,151 | 140,102 |
| NET BOOK VALUE | ||||
| At 31 March 2021 | 7,773 | 15,944 | 2,065 | 25,782 |
| At 31 March 2020 | 6,130 | 19,555 | 3,369 | 29,054 |
| 18. | FIXEDASSET INVESTMENTS | FIXEDASSET INVESTMENTS | FIXEDASSET INVESTMENTS | FIXEDASSET INVESTMENTS | |||
|---|---|---|---|---|---|---|---|
| Investments | |||||||
| MARKET | VALUE | ||||||
| At 1 April | 2020 | 3,988,405 | |||||
| Additions | 1,064,361 | ||||||
| Disposals | (1,007,471) | ||||||
| Revaluations | 756,570 | ||||||
| At 31 March 2021 | 4,801,865 | ||||||
| NET BOOK VALUE | |||||||
| At 31 March 2021 | 4,801,865 | ||||||
| At 31 March 2020 | 3,988,405 | ||||||
| 2021 | 2020 | ||||||
| F | |||||||
| Historical | cost of investments | 3,586,443 | 3,588,929 | ||||
| Analysis | ofinvestments | between funds: | |||||
| 2021 | 2020 | ||||||
| Listed investments | 4,780,526 | 3,988,405 | |||||
| UK cash | held as part of portfolio | 21,339 | |||||
| 4,801,865 | 3,988,405 | ||||||
| Cost or valuation | at 31 March 2021 is represented | by: | |||||
| Investments | |||||||
| f | |||||||
| Valuation | in 2020 | 458,852 | |||||
| Valuation | in 2021 | 756,570 | |||||
| Cost | 3,586,443 | ||||||
| 4,801,865 | |||||||
| 19. | DEBTORS:AMOUNTS | FALLING DUE WITHIN | ONE YEAR | ||||
| 2021 | 2020 | ||||||
| F | |||||||
| Other debtors | 71,540 | ||||||
| Legacies VAT |
due | 569,725 | 477,805 5,793 |
||||
| Prepayments and |
accrued income | 107,993 | 25,176 | ||||
| 749,258 | 508,774 |
| CREDITORS: | AMOUN | TS | FALLING DUE WITHIN ONE Y | EAR | |
|---|---|---|---|---|---|
| 2021 | 2020 | ||||
| E | |||||
| VAT payable | 5,918 | ||||
| Social security | and other | taxes | 13,223 | ||
| Project funding | payments | due | 279,081 | 351,947 | |
| Other creditors | 150,346 | 32,486 | |||
| Accruals and deferred | income | 180,257 | 11,908 | ||
| 628,825 | 396,341 |
| Minimum lease payments under non-cancellable operating |
leases fall due as follows: | |
|---|---|---|
| 2021 | 2020 | |
| Z | ||
| Within one year | 59,000 | 62,115 |
| Between one and five years | 26,625 | 84,625 |
| 85,625 | 146,740 |
| 2021 | 2020 | |||
|---|---|---|---|---|
| Project grant commitments | 2,659,024 | 3,192,600 | ||
| Dilapidations provision |
150,996 | 150,996 | ||
| 2,810,020 | 3,343,596 | |||
| Project grant | ||||
| commitments | ||||
| F | ||||
| Balance at 1 April | 2020 | 3,192,600 | ||
| New project grant | commitments | 460,866 | ||
| Grants payable in |
the year | (1,019,332) | ||
| Grant underspend | written | back | (4,578) | |
| Discounting ofprovisions |
29,468 | |||
| Balance at 31 March 2021 | 2,659,024 |
| 23. | MOVEMENT | MOVEMENT | IN FUNDS | IN FUNDS | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Net | ||||||||||
| movement | At | |||||||||
| At 1/4/20 | in funds | 31/3/21 | ||||||||
| F | ||||||||||
| Unrestricted | funds | |||||||||
| General fund |
3,455,034 | 1,504,072 | 4,959,106 | |||||||
| Restricted | funds | |||||||||
| Brain Tumour | Scholarship | 150,000 | 150,000 | |||||||
| Bowel Cancer | Research | Fund | 61,920 | 61,920 | ||||||
| Tom Walker | Fund - | Acute Myeloid | ||||||||
| Leukaemia | 145,988 | (8,397) | 137,591 | |||||||
| Millennium | Stadium | Charitable | Trust | 7,500 | 7,500 | |||||
| 365,408 | 8,397 | 357,011 | ||||||||
| TOTAL FUNDS | 3,820,442 | 1,495,675 | 5,316,117 | |||||||
| Net movement | in funds, | included | in the above are as follows: | |||||||
| Incoming | Resources | Gains and | Movement | |||||||
| resources f |
expended F |
losses | in funds | |||||||
| Unrestricted | funds | |||||||||
| General fund |
2,215,011 | (1,467,509) | 756,570 | 1,504,072 | ||||||
| Restricted | funds | |||||||||
| Tom Walker | Fund - | Acute Myeloid | ||||||||
| Leukaemia | (8,397) | (8,397) | ||||||||
| TOTAL FUNDS | 2,215,011 | ~1,475,906) | 756,57D | 1,495,675 |
| Comparativ | es | for | move | ment | in funds | |||
|---|---|---|---|---|---|---|---|---|
| Net | ||||||||
| movement | At | |||||||
| At 1/4/19 | in funds | 31/3/20 | ||||||
| F | F | |||||||
| Unrestricted | funds | |||||||
| General fund |
4,848,531 | (1,393,497) | 3,455,034 | |||||
| Restricted | funds | |||||||
| Brain Tumour | Scholarship | 150,000 | 150,000 | |||||
| Bowel Cancer Research | Fund | 61,920 | 61,920 | |||||
| Tom Walker | Fund - | Acute | Myeloid | |||||
| Leukaemia | 100,000 | 45,988 | 145,988 | |||||
| Millennium | Stadium | Charitable | Trust | 7,500 | 7,500 | |||
| 319,420 | 45,988 | 365,408 | ||||||
| TOTAL FUNDS | 5,167,951 | ~1,347,509) | 3,820,442 |